Physiological properties of the peritoneum in an adult peritoneal dialysis population over a three-year period

Peritoneal Dialysis International

Volumn 26, Issue 4, 2006, Pages 482-489

  Johansson, Ann Cathrine ^a,b   Haraldsson, Börje ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Peritoneal physiology; Personal Dialysis Capacity (PDC)

Indexed keywords

ANTIBIOTIC AGENT;

ABSORPTION; ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEATH; DIABETIC NEPHROPATHY; DISEASE SEVERITY; FEMALE; FUNCTION TEST; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LONG TERM CARE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MYELOMA; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; SOLUTE; SWEDEN; ULTRAFILTRATION; VASCULITIS;

EID: 33748430828     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600413     Document Type: Article

References (52)

1. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998; 54:2207-17.
2. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Hoek FJ, Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994; 45:1739-44.
3. Twardowski ZJ, Nolph KD, Khanna RA, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-47.
4. Pannekeet MM, Imholz AL, Struijk DG, Koomen GC, Langedijk MJ, Schouten N, et al. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48:866-75.
5. Haraldsson B. Assessing the individual peritoneal dialysis capacities of individual patients. A clinical tool based on the three-pore model. Kidney Int 1995; 47:1187-98.
6. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1993; 13(Suppl 2):S35-8.
7. Rippe B, Simonsen O, Stelin G. Clinical implications of a three-pore model of peritoneal transport. Adv Perit Dial 1991; 7:3-9.
8. Rippe B, Stelin G. Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism. Kidney Int 1989; 35:1234-44.
9. Rippe B, Stelin G. How does peritoneal dialysis remove small and large molecular weight solutes? Transport pathways: fact and myth. Adv Perit Dial 1990; 6:13-18.
10. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315-25.
11. Rippe B, Stelin G, Haraldsson B. Understanding the kinetics of peritoneal transport. In: Hatano M, ed. Nephrology. Tokyo: Springer Verlag; 1991: 1563-72.
12. Rippe B, Haraldsson B. Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 1994; 74:163-219.
13. Haraldsson B. Quantitative measurements of the peritoneal dialysis capacities (PDC) of individual patients. J Am Soc Nephrol 1991; 2:361.
14. Haraldsson B. Intraperitoneal fluid fluxes analyzed according to the 'three-pore' model in individual patients on CAPD. Blood Purif 1992; 10:203-8.
15. Haraldsson B. The three-pore model applied to automated peritoneal dialysis. Contrib Nephrol 1999; 129:35-43.
16. Haraldsson B, Broms E, Johansson AC. How to evaluate and optimize peritoneal dialysis treatment. Nephrol Dial Transplant 1998; 13(Suppl 6):112-16.
17. Akiba T, Ota T, Fushimi K, Tamura H, Hata T, Sasaki S, et al. Water channel AQP1, 3, and 4 in the human peritoneum and peritoneal dialysate. Adv Perit Dial 1997; 13:3-6.
18. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant 2002; 17:1085-92.
19. Bergia R. Clinical application of the Personal Dialysis Capacity (PDC) test [Abstract]. Perit Dial Int 2000; 20:109.
20. Vonesh EF, Story KO, O'Neill WT. A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group. Perit Dial Int 1999; 19:556-71.
21. Curry FE, Huxley VH, Adamson RH. Permeability of single capillaries to intermediate-sized colored solutes. Am J Physiol 1983; 245:H495-H505.
22. Michel CC. Filtration coefficients and osmotic reflexion coefficients of the walls of single frog mesenteric capillaries. J Physiol 1980; 309:341-55.
23. Flessner MF. Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol 1991; 2:122-35.
24. Carlsson O, Rosengren B-I, Rippe B. Effects of peritoneal hyaluronidase treatment on transperitoneal solute and fluid transport in the rat. Acta Physiol Scand 2000; 168: 371-6.
25. Wang T, Cheng H, Heimbürger O, Chen C, Waniewski J, Bergström J, et al. Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency. Perit Dial Int 1999; 19(Suppl 2):S106-11.
26. Rippe B, Krediet RT. Peritoneal physiology - transport of solutes. In: Gokal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht: Kluwer Academic Publishers; 1994: 69-113.
27. Flessner MF, Lofthouse J, Zakaria ER. Improving contact area between the peritoneum and intraperitoneal therapeutic solutions. J Am Soc Nephrol 2001; 12:807-13.
28. Flessner MF, Lofthouse J, Williams A. Increasing peritoneal contact area during dialysis improves mass transfer. J Am Soc Nephrol 2001; 12:2139-45.
29. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC. Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 1994; 4:1820-6.
30. Fischbach M, Haraldsson B. Dynamic changes of the total pore area available for peritoneal exchange in children. J Am Soc Nephrol 2001; 12:1524-9.
31. Johnsson E, Johansson A-C, Andréasson B-I, Haraldsson B. Unrestricted pore area is a better indicator of peritoneal function than PET. Kidney Int 2000; 58:1773-9.
32. Carlsson O, Rippe B. Enhanced peritoneal diffusion capacity of 51Cr-EDTA during the initial phase of peritoneal dialysis dwells: role of vasodilatation, dialysate 'stirring', and of interstitial factors. Blood Purif 1998; 16:162-70.
33. Zemel D, Krediet RT, Koomen GCM, Struijk DG, Arisz L. Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 1991; 11:217-33.
34. Broms EM. Personal Dialysis Capacity programme (PDC): an adequate tool for the CAPD nurse. EDTNA ERCA J 1994; 20:3-7.
35. Imai H, Satoh K, Ohtani H, Hamai K, Haseyama T, Komatsuda A, et al. Clinical application of the Personal Dialysis Capacity (PDC) test: serial analysis of peritoneal function in CAPD patients. Kidney Int 1998; 54:546-53.
36. Schaefer F, Haraldsson B, Haas S, Feber J, Mehls O. Estimation of peritoneal mass transport by three-pore model in children. Kidney Int 1998; 54:1372-9.
37. Van Biesen W, Carlsson O, Bergia R, Brauner M, Christensson A, Genestier S, et al. Personal Dialysis Capacity (PDC™) test: a multicentre clinical study. Nephrol Dial Transplant 2003; 18:788-96.
38. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9:1285-92.
39. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998; 13:962-8.
40. Fried L. Higher membrane permeability predicts poorer patient survival. Perit Dial Int 1997; 17:387-9.
41. Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int 2000; 57:314-20.
42. Wang T, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998; 13:1242-9.
43. Khan IH, Catto GRD, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415-18.
44. Van Manen J, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PMM, Krediet RT, for the NECOSAD Study Group. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 2002; 40:82-9.
45. Fried L, Bernardini J, Piraino B. A comparison of the Charlson Comorbidity Index and the Davies Score to predict outcomes in incident PD patients [Abstract]. Perit Dial Int 2001; 21 (Suppl 2):S22.
46. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15:953-60.
47. Tzamaloukas AH, Murata GH, Malhotra D, Rao P, Piraino B, Bernardini J, et al. Small-solute clearances in diabetic subjects on continuous ambulatory peritoneal dialysis: comparison to nondiabetic subjects. Adv Perit Dial 1999; 15:179-82.
48. Hiroshige K, Watanabe Y, Suda T, Yuu K, Ohtani A. Relation of calcified macroangiopathy to peritoneal small solute transport property. Perit Dial Int 1998; 18:650-3.
49. Lameire NH, Vanholder R, Veyt D, Lambert MC, Ringoir S. A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992; 42:426-32.
50. Selgas R, Fernandez Reyes MJ, Bosque E, Bajo MA, Borrego F, Jimenez C, et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23:64-73.
51. Davies SJ. Longitudinal relationship between solute transport and ultrafilration capacity in peritoneal dialysis patients. Kidney Int 2004; 66:2437-45.
52. Williams JD, Craig KJ, Topley N, von Ruhland C, Fallon M, Newman GR, et al., on behalf of the Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.